- Home
- NERV vs PRZO Comparison
NERV vs PRZO Comparison
Compare NERV & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NERV | PRZO |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 25.1M |
| IPO Year | 2014 | 2023 |
Fundamental Metrics
Financial Performance| Metric | NERV | PRZO |
|---|---|---|
| Price | $3.97 | $1.02 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 40.4K | ★ 461.3K |
| Earning Date | 11-05-2025 | 08-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,007,440.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 80.42 |
| 52 Week Low | $1.15 | $0.53 |
| 52 Week High | $12.46 | $3.16 |
Technical Indicators
Market Signals| Indicator | NERV | PRZO |
|---|---|---|
| Relative Strength Index (RSI) | 51.62 | 30.53 |
| Support Level | $3.70 | $1.13 |
| Resistance Level | $4.07 | $1.20 |
| Average True Range (ATR) | 0.29 | 0.07 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 62.37 | 2.46 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.